Peptide Research Index
⚠️ Educational only · Not medical advice · Consult a doctor · Most peptides are research-only / not FDA-approved for human use
⚠️ Educational only · Not medical advice · Consult a doctor · Most peptides are research-only / not FDA-approved for human use
Also: Nicotinamide Adenine Dinucleotide, NAD Plus, Beta-Nicotinamide Adenine Dinucleotide
⚡LongevityNAD+ is a critical coenzyme in every cell, essential for mitochondrial energy production (oxidative phosphorylation), DNA repair via PARP and sirtuin activation, and circadian rhythm regulation. Levels decline ~50% between ages 40-60, contributing to metabolic dysfunction and aging.
Rajman et al. (Cell Metabolism): Comprehensive review demonstrating NAD+ decline as a hallmark of aging, with restoration improving mitochondrial function, stem cell renewal, and lifespan in animal models.
strongZhang et al. (Science): NAD+ supplementation restores mitochondrial function in aged mice, improving muscle stem cell function and extending lifespan.
preclinicalCamacho-Pereira et al. (Cell Metabolism): Identifies CD38 as the primary NAD-consuming enzyme that increases with age, explaining the progressive NAD+ decline.
preclinicalYoshino et al.: Review of human clinical trials for NAD+ precursors (NMN, NR) showing safe elevation of blood NAD+ levels with improvements in insulin sensitivity and muscle function.
moderateGenerally well-tolerated. IV NAD+ infusions may cause chest tightness, nausea, and cramping during administration. Subcutaneous injection is better tolerated. Oral precursors (NMN, NR) have good safety profiles in clinical trials.
⚠️ For educational purposes only. Not medical advice. Consult a healthcare professional before using any peptide.
SubQ: 50-200mg daily. IV: 250-500mg over 2-4 hours. Start low — rapid NAD+ elevation can cause nausea and flushing. Oral precursors (NMN/NR) are an alternative.
Week 1
Increased energy, mental clarity, reduced brain fog
Weeks 2-4
Improved exercise recovery, better sleep quality, mood stabilization
Month 2-3
Measurable improvements in metabolic markers, sustained energy throughout the day
Long-term
NAD+ level restoration; potential longevity benefits (animal data for lifespan extension)
| Side Effect | Incidence | Severity |
|---|---|---|
Nausea during infusion Dose-dependent; resolved by slowing infusion rate | ~30% (IV route) | moderate |
Flushing/warmth | ~20% of users | mild |
Chest tightness Transient during infusion, resolves within minutes | ~15% (IV route) | mild |
Injection site discomfort | ~10% (SubQ) | mild |
Incidence rates sourced from published clinical trial data where available; otherwise based on community research observations.
Weekly Peptide Research
New studies · vendor alerts · protocol tips
No spam. Unsubscribe anytime. Research use only.